191 related articles for article (PubMed ID: 2438218)
1. Protection against experimental allergic encephalomyelitis with complete Freund's adjuvant is unaffected by ionizing irradiation.
Weber F; Hempel K
Int Arch Allergy Appl Immunol; 1987; 83(2):174-7. PubMed ID: 2438218
[TBL] [Abstract][Full Text] [Related]
2. Protection against experimental allergic encephalomyelitis with complete Freund's adjuvant is unaffected by prostaglandin synthesis inhibition.
Weber F; Hempel K
Int Arch Allergy Appl Immunol; 1989; 89(2-3):242-5. PubMed ID: 2474512
[TBL] [Abstract][Full Text] [Related]
3. Suppression of experimental allergic encephalomyelitis by transfer of lymph node cells from Lewis rats pretreated with complete Freund's adjuvant.
Englert D; Hempel K
Int Arch Allergy Appl Immunol; 1981; 66(3):326-31. PubMed ID: 6170593
[TBL] [Abstract][Full Text] [Related]
4. Liposomes containing myelin basic protein (BP) suppress but do not induce allergic encephalomyelitis in Lewis rats.
Willenborg DO; Higgins TJ
Aust J Exp Biol Med Sci; 1981 Apr; 59(Pt 2):135-41. PubMed ID: 6167253
[TBL] [Abstract][Full Text] [Related]
5. Heat shock proteins and experimental autoimmune encephalomyelitis (EAE): I. Immunization with a peptide of the myelin protein 2',3' cyclic nucleotide 3' phosphodiesterase that is cross-reactive with a heat shock protein alters the course of EAE.
Birnbaum G; Kotilinek L; Schlievert P; Clark HB; Trotter J; Horvath E; Gao E; Cox M; Braun PE
J Neurosci Res; 1996 May; 44(4):381-96. PubMed ID: 8739158
[TBL] [Abstract][Full Text] [Related]
6. Unresponsiveness to experimental allergic encephalomyelitis in Lewis rats pretreated with complete Freund's adjuvant.
Hempel K; Freitag A; Freitag B; Endres B; Mai B; Liebaldt G
Int Arch Allergy Appl Immunol; 1985; 76(3):193-9. PubMed ID: 2579028
[TBL] [Abstract][Full Text] [Related]
7. Modification of the clinical and histopathologic expression of experimental allergic encephalomyelitis by the vasoactive amine antagonist cyproheptadine.
Waxman FJ; Taguiam JM; Whitacre CC
Cell Immunol; 1984 Apr; 85(1):82-93. PubMed ID: 6201289
[TBL] [Abstract][Full Text] [Related]
8. The significance of circulating and cell-bound antibodies in experimental allergic encephalomyelitis.
Gonatas NK; Gonatas JO; Stieber A; Lisak R; Suzuki K; Martenson RE
Am J Pathol; 1974 Sep; 76(3):529-48. PubMed ID: 4547331
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99.
Liu JQ; Bai XF; Shi FD; Xiao BG; Li HL; Levi M; Mustafa M; Wahren B; Link H
Int Immunol; 1998 Aug; 10(8):1139-48. PubMed ID: 9723700
[TBL] [Abstract][Full Text] [Related]
10. Transfer of allergic encephalomyelitis with spleen cells from donors sensitized with myelin basic protein in incomplete Freund's adjuvant.
Namikawa T; Richert JR; Driscoll BF; Kies MW; Alvord EC
J Immunol; 1982 Feb; 128(2):932-4. PubMed ID: 6172517
[TBL] [Abstract][Full Text] [Related]
11. Regulation of experimental allergic encephalomyelitis. Part 4. Further characterization of postrecovery suppressor cells.
Killen JA; Swanborg RH
J Neuroimmunol; 1982 Oct; 3(2):159-66. PubMed ID: 6181092
[TBL] [Abstract][Full Text] [Related]
12. Regulation of experimental allergic encephalomyelitis. III. Demonstration of effector cells in tolerant rats.
Holda JH; Swanborg RH
Eur J Immunol; 1981 Apr; 11(4):338-40. PubMed ID: 6166483
[TBL] [Abstract][Full Text] [Related]
13. Suppression of experimental allergic encephalomyelitis with thoracic duct lymphocytes.
Frost H; Swanborg RH
Int Arch Allergy Appl Immunol; 1980; 63(2):153-8. PubMed ID: 6158482
[TBL] [Abstract][Full Text] [Related]
14. Limiting-dilution analysis of the frequency of myelin basic protein-reactive T cells in Lewis, PVG/c and BN rats. Implication for susceptibility to autoimmune encephalomyelitis.
Matsumoto Y; Kawai K; Tomita Y; Fujiwara M
Immunology; 1990 Feb; 69(2):215-21. PubMed ID: 1689693
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide and the immunomodulation of experimental allergic encephalomyelitis.
Gold DP; Schroder K; Powell HC; Kelly CJ
Eur J Immunol; 1997 Nov; 27(11):2863-9. PubMed ID: 9394811
[TBL] [Abstract][Full Text] [Related]
16. Studies on the refractoriness to reinduction of experimental allergic encephalomyelitis in Lewis rats that have recovered from one episode of the disease.
MacPhee IA; Mason DW
J Neuroimmunol; 1990 Apr; 27(1):9-19. PubMed ID: 1690754
[TBL] [Abstract][Full Text] [Related]
17. Accelerated response to reinoculation in experimental allergic encephalomyelitis: histopathologic study.
Levine S; Saltzman A
J Neuropathol Exp Neurol; 1991 Mar; 50(2):126-33. PubMed ID: 1707089
[TBL] [Abstract][Full Text] [Related]
18. Abrogation of induced resistance to experimental allergic encephalomyelitis in guinea pigs by host-versus-graft reaction.
Kozovska M; Staykova M; Goranov I
J Neuroimmunol; 1990; 29(1-3):157-63. PubMed ID: 1698813
[TBL] [Abstract][Full Text] [Related]
19. The role of antigen absorption in the resistance of brown-Norway rats to experimental allergic encephalomyelitis.
Levine S; Saltzman A
Immunol Lett; 1988 Oct; 19(2):103-8. PubMed ID: 2466773
[TBL] [Abstract][Full Text] [Related]
20. Autoimmune effector cells. III. Role of adjuvant and accessory cells in the in vitro induction of autoimmune encephalomyelitis.
Killen JA; Swanborg RH
J Immunol; 1982 Aug; 129(2):759-63. PubMed ID: 6177781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
